Opinion|Videos|August 12, 2024
Tailoring Insulin Therapy: Key Considerations for Dosing and Glucose Control
Author(s)Medha Munshi, MD, John E. Anderson, MD
The panel examines crucial factors in determining appropriate medication dosages and managing glucose levels for elderly patients with type 2 diabetes.
Advertisement
Episodes in this series
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Advertisement
Advertisement
Trending on Patient Care Online
1
When Night Sweats Signal Something Other Than Menopause
2
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
3
4 FDA Decisions for Primary Care to Know from October 2026
4
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
5